AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 274 filers reported holding AMEDISYS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,067,552 | +0.7% | 97,083 | -1.5% | 1.46% | +13.2% |
| Q2 2023 | $9,008,120 | +26.5% | 98,514 | +1.7% | 1.29% | +19.6% |
| Q1 2023 | $7,123,097 | +47.4% | 96,847 | +67.4% | 1.08% | +36.5% |
| Q4 2022 | $4,831,703 | -15.8% | 57,837 | -2.4% | 0.79% | -19.8% |
| Q3 2022 | $5,736,000 | -49.3% | 59,265 | +53.6% | 0.99% | -17.7% |
| Q4 2020 | $11,317,000 | +28.2% | 38,582 | +3.4% | 1.20% | -7.1% |
| Q3 2020 | $8,826,000 | +16.1% | 37,331 | -2.5% | 1.29% | +5.9% |
| Q2 2020 | $7,604,000 | +34.0% | 38,301 | +23.9% | 1.22% | -3.1% |
| Q1 2020 | $5,675,000 | -19.7% | 30,917 | -27.0% | 1.26% | +8.7% |
| Q4 2019 | $7,068,000 | -21.7% | 42,341 | -41.4% | 1.16% | +1.4% |
| Q3 2018 | $9,023,000 | +2.9% | 72,210 | -29.6% | 1.14% | -5.6% |
| Q2 2018 | $8,770,000 | +52.0% | 102,621 | -10.2% | 1.21% | +14.7% |
| Q2 2016 | $5,768,000 | +6.1% | 114,262 | +1.6% | 1.05% | +0.3% |
| Q1 2016 | $5,438,000 | – | 112,505 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 751,719 | $70,210,555 | 6.45% |
| Crabel Capital Management, LLC | 83,093 | $7,761 | 6.24% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,033,497 | $96,528,620 | 5.06% |
| Vazirani Asset Management LLC | 35,000 | $3,269,000 | 5.00% |
| Ergoteles LLC | 33,863 | $3,162,804 | 4.64% |
| Sand Grove Capital Management LLP | 282,850 | $26,418 | 3.29% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 162,973 | $15,221,678 | 2.48% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 80,923 | $7,558 | 2.44% |
| Melqart Asset Management (UK) Ltd | 350,328 | $32,720,635 | 2.34% |
| Westchester Capital Management, LLC | 850,386 | $79,426,052 | 2.32% |